Serum Levels of Soluble IL-6 Receptor in Multiple Myeloma as Indicator of Disease Activity

Helen Α. Papadaki(University of Crete), George D. Eliopoulos(University of Crete), Fotini Markidou(University of Crete), Andreas Foudoulakis(University of Crete), Michael G. Alexandrakis(University of Crete), Despina Kyriakou(University of Crete)

Acta Haematologica

February 17, 2009

10.1159/000203682

Cited by 46

Related Papers

Mutations in proto-oncogene GFI1 cause human neutropenia and target ELA2

|Nature Genetics|2003|389

Anemia of chronic disease in rheumatoid arthritis is associated with increased apoptosis of bone marrow erythroid cells: improvement following anti–tumor necrosis factor-α antibody therapy

|Blood|2002|266

Functional, molecular and proteomic characterisation of bone marrow mesenchymal stem cells in rheumatoid arthritis

|Annals of the Rheumatic Diseases|2007|154

Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor alpha–mediated effect

|Blood|2002|138

Multicentric Castleman's disease

|AIDS|2004|121